Genotypes | p53+/- | p53 +/+ | ||
---|---|---|---|---|
 | Atm +/- (n = 55) | Atm +/+ (n = 61) | Atm +/- (n = 47) | Atm +/+ (n = 53) |
Mammary carcinoma | 32 (58%)a* | 19 (31%) | 0 (0%) | 1 (2%) |
Lymphoma | 24 (44%)b | 29 (48%) | 26 (55%) | 22 (42%) |
Squamous cell carcinoma | 1 (2%) | 1 (2%) | 0 (0%) | 0 (0%) |
Histiocytic sarcoma | 1 (2%)c | 0 (0%) | 0 (0%) | 0 (0%) |
Basal cell carcinoma | 0 (0%) | 1 (2%) | 0 (0%) | 0 (0%) |
Granulocytic leukaemia | 0 (0%) | 1 (2%) | 0 (0%) | 0 (0%) |
Ovarian carcinoma | 0 (0%) | 1 (2%) | 0 (0%) | 0 (0%) |
Nonthymic lymphoma (NOS) | 0 (0%) | 1 (2%) | 3 (6%) | 0 (0%) |
Solid tumour (NOS) | 1 (2%)d | 1 (2%)e | 1 (2%) | 1 (2%) |
Number of mammary carcinomas/mousee | 52/55 (0.95)** | 28/61 (0.46) | 0/47 (0.00) | 1/53 (0.02) |